Weight management study for overweight adults
Part of Hormones & metabolism clinical trials.
This study tests a new injectable medicine for weight management in adults who are overweight. It aims to see how the medicine works in the body and how it affects weight.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 60 years old.
- You must weigh at least 60 kg (about 132 pounds) and have a body mass index (BMI) between 24 and 28.
- You must not have used any GLP-1 medicines before.
- You cannot be pregnant, breastfeeding, or planning to become pregnant during the study.
- You cannot have a history of pancreatitis, gallbladder disease, or certain serious health conditions.
- You must not have donated blood or lost more than 400 mL of blood in the last 3 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if an investigational medication, GZR18 (given as an injection), affects how the body handles metformin (a common diabetes medicine). It is for overweight or obese adults. The goal is to help researchers understand if the two medicines can be used together safely.
This study tests a new weight-loss medicine called HRS-1596. It is given as a tablet to see if it is safe and how well it works. The study first gives a single dose to healthy adults, then multiple doses to people with obesity.
This study is for people who finished a previous weight loss trial and want to continue treatment with an injectable medication GZR18. It tests how well the medicine works over a longer period.
This trial tests how a new drug called GZR18 (given as an injection) affects the body in people with different levels of kidney function. It aims to find the right dose and check for side effects, which could help guide treatment for people with kidney issues.
This study tests a new drug called GZR18 to see how it works in people with different levels of liver function. It aims to help find the right dose and check safety.
This study tests an investigational medicine called GZR101-80 for people with type 2 diabetes. It aims to see how well it controls blood sugar and how safe it is.
Hear when a new Type 2 diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.